Amgen (AMGN) Revenue — Quarter Ended Sep 30, 2024
Revenue increased in the current quarter compared to the prior quarter. Revenue also rose relative to the same quarter one year earlier.
Key takeaway
Quarter ended Sep 30, 2024 · FY2024 Q3
Revenue increased in the current quarter compared to the prior quarter. Revenue also rose relative to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$8.5B
Revenue reported for this quarter.
Quarter-over-quarter
+1.4%
Change from the immediately preceding quarter.
Year-over-year
+23.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$32.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $8.2B | +19.8% |
| Mar 31, 2024 | $7.4B | +22.0% |
| Jun 30, 2024 | $8.4B | +20.1% |
| Sep 30, 2024 | $8.5B | +23.2% |
Revenue performance
The reported revenue direction is positive, with growth from both the immediately preceding quarter and the same quarter a year ago.
Quarterly comparison
Compared with the immediately preceding quarter, revenue improved. Compared with the same quarter one year earlier, revenue also showed an increase.
What to watch
No filing context is provided to explain the revenue changes; monitor future filings for underlying drivers.